CAVH를 이용하여 치료한 비신장성 질환
Continuous arteriovenous hemofiltration(CAVH) is used to treat hemodynamically unstable patients with renal failure, refractory ascites and edema, sepsis, or ARDS patients. Patients received CAVH during a 3-year-period from March 1994 to February 1997. Their clinical findings were analyzed retrospec...
Saved in:
Published in | Kidney research and clinical practice Vol. 17; no. 3; pp. 476 - 482 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Korean |
Published |
대한신장학회
30.05.1998
|
Online Access | Get full text |
Cover
Loading…
Abstract | Continuous arteriovenous hemofiltration(CAVH) is used to treat hemodynamically unstable patients with renal failure, refractory ascites and edema, sepsis, or ARDS patients. Patients received CAVH during a 3-year-period from March 1994 to February 1997. Their clinical findings were analyzed retrospectively, and the results were as follows', They were 6 men and 3 women from 28 to 62 years. 3 patients had ARDS, 2 patients had CHF. The remainder had SLE, liver cirrhosis, septic shock with cholangitis, diabetic ketoacidosis with pulmo- nary edema. The duration of treatment ranged from 30 to 50 hours, with a mean of 41.6±6.9 hours. The total fluid repalcernent was 22.4±1.7L and the mean fluid loss was 3.9±2.6L. Changes in serum BUN, creatinine, sodium, potasium before and after treat- ment were not significantly different. The compli- cation of CAVH is clotting of hemofilter, hypoten- sion, bleeding, and mild thrombocytopenia. 2 of 3 ARDS patients expired during CAVH, liver cirrhosis patient expired later due to hepatic encephalopathy, and, finally 6 patients discharged with improved conditions. In conclusion, CAVH, a safe and effective therapy in hemodynamically unstable patients with renal failure, refractory ascites and edema, sepsis, or ARDS patients. |
---|---|
AbstractList | Continuous arteriovenous hemofiltration(CAVH) is used to treat hemodynamically unstable patients with renal failure, refractory ascites and edema, sepsis, or ARDS patients. Patients received CAVH during a 3-year-period from March 1994 to February 1997. Their clinical findings were analyzed retrospectively, and the results were as follows', They were 6 men and 3 women from 28 to 62 years. 3 patients had ARDS, 2 patients had CHF. The remainder had SLE, liver cirrhosis, septic shock with cholangitis, diabetic ketoacidosis with pulmo- nary edema. The duration of treatment ranged from 30 to 50 hours, with a mean of 41.6±6.9 hours. The total fluid repalcernent was 22.4±1.7L and the mean fluid loss was 3.9±2.6L. Changes in serum BUN, creatinine, sodium, potasium before and after treat- ment were not significantly different. The compli- cation of CAVH is clotting of hemofilter, hypoten- sion, bleeding, and mild thrombocytopenia. 2 of 3 ARDS patients expired during CAVH, liver cirrhosis patient expired later due to hepatic encephalopathy, and, finally 6 patients discharged with improved conditions. In conclusion, CAVH, a safe and effective therapy in hemodynamically unstable patients with renal failure, refractory ascites and edema, sepsis, or ARDS patients. |
Author | 김치학 이인상 이인태 박정현 |
Author_xml | – sequence: 1 fullname: 이인상 – sequence: 2 fullname: 박정현 – sequence: 3 fullname: 이인태 – sequence: 4 fullname: 김치학 |
BookMark | eNrjYmDJy89LZWHgNDIyNNS1NDQ24mDgLS7OTDIwNTA3NjGzsOBkMHJ2DPN4vXSPwpu5W97MWvl26ow309covNk54_XinrdT5yi83tnypnvBm3lL37RsVHizvOPtzBk8DKxpiTnFqbxQmptB2s01xNlDNzuzuDi-oCgzN7GoMt7QwsLSxNDYGL8sAO1mPT0 |
ContentType | Journal Article |
DBID | HZB Q5X |
DatabaseName | KISS Korean Studies Information Service System (KISS) B-Type |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | CAVH를 이용하여 치료한 비신장성 질환 |
ExternalDocumentID | 1889413 |
GroupedDBID | AACTN ACGFS ADBBV ALMA_UNASSIGNED_HOLDINGS BCNDV FDB GROUPED_DOAJ HZB O-L PC. Q5X RPM |
ID | FETCH-kiss_primary_18894133 |
ISSN | 2211-9132 |
IngestDate | Fri Sep 08 04:48:59 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | Korean |
LinkModel | OpenURL |
MergedId | FETCHMERGED-kiss_primary_18894133 |
Notes | The Korean Society of Nephrology |
PageCount | 7 |
ParticipantIDs | kiss_primary_1889413 |
PublicationCentury | 1900 |
PublicationDate | 19980530 |
PublicationDateYYYYMMDD | 1998-05-30 |
PublicationDate_xml | – month: 05 year: 1998 text: 19980530 day: 30 |
PublicationDecade | 1990 |
PublicationTitle | Kidney research and clinical practice |
PublicationTitleAlternate | Kidney Research and Clinical Practice(구 대한신장학회지) |
PublicationYear | 1998 |
Publisher | 대한신장학회 |
Publisher_xml | – name: 대한신장학회 |
SSID | ssib050734688 ssj0000684936 |
Score | 2.8742247 |
Snippet | Continuous arteriovenous hemofiltration(CAVH) is used to treat hemodynamically unstable patients with renal failure, refractory ascites and edema, sepsis, or... |
SourceID | kiss |
SourceType | Publisher |
StartPage | 476 |
Title | CAVH를 이용하여 치료한 비신장성 질환 |
URI | https://kiss.kstudy.com/ExternalLink/Ar?key=1889413 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1PS9xAFB-2HqSXorWl9R85dE6SkmQmycxxko0sFj1p8SZNNgulsBZdL549CHoVV1ERRETwIvSi9Btt9jv0vUliYllK20t4vHnz5s38JpP3knkTQj7YPHETn8UmYMtMnnDPlGmHm45jibjjpyLWX3SXV7zWGl9ad9cbjcfarqWdXvwx2R2ZV_I_qAIPcMUs2X9A9kkpMIAGfOEKCMP1rzAO1ecWjQKqXBqECzQKqWzSgGtCUSVp1KTSpVJojk9VLhRIzYJ6jIqwFMKyAMuEViCg2NL1ItSPHE4DWytQPhVC10NNdf_209d2F1aZ4gihImuuTL4sM7JKkJ8bDIS2U4BRdiUCJlloHzabE020XvA_aWmiFhlWIkp3zKr1Pu-0rN565GmAbvkBB-cptg4DhPWKMRo1MoUmTSiQr9ZWB-Je3HTw_EHg1yY8q63q3P_ttO48fBJCcvxh8gtmu7VgHlYycLIZ94qD4HKfQHCp_1f51DL4ABAibNe8mdUJ8qoIQwyVz6lJ0vi2-ZqMLxcbLaaIg1NrcP3TyM5_ZKe3w6N-dnxnZA_9wdXh8OjMGDzsZQeX2cV1tndvZDf7w5P-GzKzGK2GLRPb2_ien2KyUZjP3pKx7mY3fYe73KSIXZ-1ZQy3cMcXicc8N7W_WG3pOLL9nkyN0jA9mj1DXlbAzZKx3tZOOgcOXC-e12P1CzZqM7M |
link.rule.ids | 315,786,790 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CAVH%EB%A5%BC+%EC%9D%B4%EC%9A%A9%ED%95%98%EC%97%AC+%EC%B9%98%EB%A3%8C%ED%95%9C+%EB%B9%84%EC%8B%A0%EC%9E%A5%EC%84%B1+%EC%A7%88%ED%99%98&rft.jtitle=Kidney+research+and+clinical+practice&rft.au=%EC%9D%B4%EC%9D%B8%EC%83%81&rft.au=%EB%B0%95%EC%A0%95%ED%98%84&rft.au=%EC%9D%B4%EC%9D%B8%ED%83%9C&rft.au=%EA%B9%80%EC%B9%98%ED%95%99&rft.date=1998-05-30&rft.pub=%EB%8C%80%ED%95%9C%EC%8B%A0%EC%9E%A5%ED%95%99%ED%9A%8C&rft.issn=2211-9132&rft.volume=17&rft.issue=3&rft.spage=476&rft.externalDocID=1889413 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-9132&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-9132&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-9132&client=summon |